Dr John M McCall

Dr McCall is President of PharMac LLC, a drug discovery, project management, project evaluation and research organisation.  He is a member of the Scientific Advisory Boards for MHTSC (Michigan High Throughput Screening Center), CINRG (Co-operative International Neuromuscular Research Group), Deciphera, Verseon, Reaction Biology, CeeTox, Lycera, Scripps, and PharmOptima. He is a founding member of the Scientific Advisory Board of Aväant Pharmaceuticals, an Anglo/Indian drug development company. He is Chairman of the Development Team and a member of the Steering Committee of the NINDS Spinal Muscular Atrophy Initiative. He is a member of the Board of Directors of ADMETRx.

He previously worked for Pfizer Inc as Vice President Global Research and Development. During this time he was a member of the Pfizer Discovery Management Committee, Global Discovery and Global Research Technology Boards, a member of the Research Technology Leadership Team and Global Discovery Chemistry.  Prior to Pfizer, he was Vice President Global Discovery Chemistry at Pharmacia, where he was responsible for Structural and Analytical Chemistry, Medicinal and Combinatorial Chemistry, Computational Chemistry and Cheminformatics.